Zymeworks (ZYME) PT Lowered to $18 at JPMorgan
Tweet
Share
E-mailGet Alerts ZYME Hot Sheet
Price: $26.57 -2.35%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
JPMorgan analyst Jessica Fye lowered the price target on Zymeworks (NYSE: ZYME) to $18.00 (from $32.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Infleqtion, Inc (INFQ) PT Raised to $22 at Citi
- Futu Holdings Limited (FUTU) PT Raised to $157 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
